BrainsWay Reports Open Market Stock Purchase by Board Member Yossi Ben Shalom
BURLINGTON, Mass. and JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported a recent open market purchase of BrainsWay American Depositary Receipts (ADRs) by Yossi Ben Shalom, an independent Director on the Company’s Board.
Related news for (BWAY)
- BrainsWay Enters $20 Million PIPE
- BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
- BrainsWay Announces Appointment of Ido Marom as CFO
- BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
- BrainsWay Announces Appointment of Ami Boehm as New Chairman